The purpose of this study was to assess the diagnostic performance of combined DKI and DSC-MRI maps for in vivo assessment of the 2016 WHO integrated glioma grades.
Histogram parameters of DKI show a higher diagnostic performance than those of DSC-MRI in stratifying gliomas according to the integrated molecular approach of 2016 CNS WHO. However, DSC-MRI may provide additional insight into the MGMT methylation profile of primary IDH wild-type GBM. Thus, combined DKI and DSC-MRI provide promising potential biomarkers for glioma.
This abstract and the presentation materials are available to members only; a login is required.